Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients

Documenti analoghi

• Association and Comparative Analysis of Four Inflammatory Indices With 90‐Day Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
  di: Xinping Bai, et al.
  Pubblicazione: (2026)
• Association of Admission Glucose‐to‐Lymphocyte Ratio With 90‐Day Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis
  di: Dong Zhang, et al.
  Pubblicazione: (2026)
• The Mediating Effect of Inflammatory Biomarkers in the Associations Between Sarcoidosis and Incident Ischemic Stroke: A Prospective Cohort Study
  di: Zihong Bai, et al.
  Pubblicazione: (2026)
• Triglyceride–Glucose Index and Short‐Term Functional Prognosis in Patients With Acute Ischemic Stroke: A Retrospective Study
  di: Zhuqing Wu, et al.
  Pubblicazione: (2025)
• Edaravone's Safety Profile in Acute Ischemic Stroke
  di: Laurence K. J. Batino, et al.
  Pubblicazione: (2024)